Gates to address G20 leaders about foreign aid, Robin Hood tax

NewsGuard 100/100 Score

Bill Gates, co-chair of the Bill & Melinda Gates Foundation, is expected to tell G20 leaders on Thursday that tightening foreign aid budgets amid the current economic crisis "is counterproductive and pointless," the Toronto Star reports. "'Aid is a small investment that generates a huge return. Those are precisely the investments we should spare when it's time to make cuts,' he says in prepared comments seen by the" Star, according to the newspaper.

"If the aid budgets of advanced economies are trimmed, important aspects of the global development agenda will not be tackled, Gates says," adding, "Foreign aid 'spurs innovation by funding pilot projects that poor countries would not undertake themselves. It also pays for global public goods like scientific research,'" the Star writes (Whittington, 11/2). According to the Guardian, Gates will also tell the G20 group "that they could raise an extra $48 billion (30 billion pounds) a year to fight global poverty by levying a small tax on share and bond trading," a so-called Robin Hood tax, adding the "levy on finance would help hard-pressed rich nations to meet their aid pledges to the poor" (Elliott, 11/2).


http://www.kaiserhealthnews.orgThis article was reprinted from kaiserhealthnews.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
New research pinpoints key pathways in prostate cancer's vulnerability to ferroptosis